Oncology Peer Review On-The-Go: The COVID-19 Pandemic's Impact on Cancer Screenings

Podcast

The latest episode of “Oncology Peer Review On-The-Go” examines how the coronavirus disease 2019 pandemic is impacting routine cancer screenings, and the strategies to get those appointments rescheduled.

In this week’s episode, CancerNetwork speaks with Christopher McNair, PhD, of the Sidney Kimmel Cancer Center – Jefferson Health for an in-depth discussion on how the coronavirus disease 2019 (COVID-19) pandemic has impacted cancer screenings.

Then, CancerNetwork speaks with Lisa Berry Edwards, managing director of external affairs for the PreventCancer Foundation, to talk about their “Back on the Books” initiative working to get cancer screenings and regular appointments rescheduled during the pandemic.

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify or anywhere podcasts are available, or listen online at www.cancernetwork.com.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.
Related Content